Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

amino-acid, glucose, and electrolyte solution × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

Specimen Handling 409 Magnetic Resonance Spectroscopy 334 pembrolizumab 290 Biopsy 228 Carboplatin 220 Cisplatin 185 Cyclophosphamide 169 Nivolumab 168 Gemcitabine 162 Paclitaxel 150 Bevacizumab 121 Radiotherapy 112 atezolizumab 99 Docetaxel 96 Dexamethasone 96 fludarabine 91 venetoclax 90 Oxaliplatin 90 Rituximab 86 durvalumab 83 Radiation 82 Fluorouracil 81 Pemetrexed 79 Doxorubicin 79 Ipilimumab 75 Prednisone 73 Taxes 71 Capecitabine 67 X-Rays 66 Leucovorin 66

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03049189 2026-04-06

COMPETE

ITM Solucin GmbH

Phase 3 Active not recruiting

324 enrolled 15 charts

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡